Livonia, MI, United States of America

Vaishalee A Padgaonkar

This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vaishalee A Padgaonkar. Retrieved from https://idiyas.com/inventor/vaishalee-a-padgaonkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Vaishalee A Padgaonkar

Introduction

Vaishalee A Padgaonkar is an accomplished inventor based in Livonia, MI (US). He has made significant contributions to the field of medical treatments, particularly in the area of neutrophil chemotaxis. His innovative approach has the potential to impact patient care positively.

Latest Patents

Vaishalee holds a patent for a method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor. This invention provides a method of treating or preventing neutrophil migration, which is crucial for various medical conditions. The patent highlights the importance of MEK inhibitors in managing neutrophil activity.

Career Highlights

Vaishalee A Padgaonkar is associated with Warner-Lambert Company, where he has been able to apply his expertise in developing innovative medical solutions. His work has been instrumental in advancing therapeutic methods that address critical health issues.

Collaborations

He has collaborated with notable colleagues such as Vijaykumar M Baragi and Madhav Narasimha Devalaraja, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Vaishalee A Padgaonkar's contributions to the field of medicine through his patent on neutrophil chemotaxis exemplify the impact of innovative thinking in healthcare. His work continues to inspire advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…